The federal official looking into how a Pennsylvania woman contracted an infection that could herald the emergence of an antibiotic-resistant “superbug” said the discovery was big but not unexpected.

“No, I don’t think we’re at all surprised to have found it,” Beth Bell, who leads the federal Centers for Disease Control and Prevention’s antibiotic resistance work, said Tuesday.

Since November, when researchers from China and Britain issued a report that showed the same bacterial gene – known as MCR-1 – that was found in the woman here was found in pigs and people in China, the CDC has been on the lookout for the first case in the U.S.

The gene is of concern because it can be easily transferred to other bacteria, and it allows the bacteria to become resistant to Colistin, an antibiotic often seen as a “last resort” drug to knock down infections because it is used so rarely in the U.S.

Advertise with us

The gene has also been found in other parts of the world, including in Europe, and researchers knew it was only a matter of time before it made its way to the U.S.

“And we’ll probably and likely find more,” said Dr. Bell, who took part in a phone press conference with Pennsylvania Department of Health officials Tuesday updating what has happened with the case since it first became known last Thursday.

Dr. Bell said the 49-year-old woman was never quarantined after detection and is doing well. State officials said Pennsylvania law prevented them from releasing anything about the woman, who was found to have the MCR-1 gene in the e. coli bacteria that caused her an infection in April.

In a separate interview, researchers with the Walter Reed Army Institute of Research who detected the gene said the woman is doing well in part because testing at Walter Reed helped figure out which antibiotics would work.

Though news reports last week indicated the bacteria that infected the woman was antibiotic resistant, it was not. It was resistant to Colistin and many others, but not all, said Patrick McGann, a researcher and lead author of the journal article that announced the discovery Thursday.

Advertise with us

He and his staff tested the MCR-1 gene against 20 different antibiotics and found it was resistant to 14 of those 20 drugs – including Colistin - and “sensitive,” or effective, to six of them.

“That showed us that this [gene] was not the end of the world, but it is still a concern that it is resistant to so many” antibiotics, Dr. McGann said.

Once the gene was identified, researchers around the globe began retesting old human and animal samples, with one finding it in China from a sample taken in 1984, and another in France in 2003.

“So the gene was obviously floating around,” Dr. McGann said. “It was just that no one was looking for it.”

It was only through timing and a bit of luck that the Army researchers detected it.

Advertise with us

In the wake of the findings over the last year around the world of the MCR-1 gene, the Army only decided at the beginning of May to begin testing for the gene using a new technique out of Switzerland to detect it in the bacteria.

It just so happened the woman visited a military-related health clinic somewhere in Pennsylvania April 26 with a urinary tract infection.

“I have no doubt if she went to a normal [non-military] clinic it would have been completely missed,” Dr. McGann said.

The small military clinic does not have its own lab, so her urine sample was sent to Walter Reed, where Dr. McGann’s staff has state-of-the-art equipment to test and eventually genome-sequence the bacteria.

Dr. McGann said that during the second week of May, his staff members picked up the biweekly supply of possible bacteria to be tested from Walter Reed, and on May 18 for the first time he asked them to do the test for the MCR-1 gene.

Advertise with us

“I told them, ‘It probably won’t come back positive, but do it anyway,’ since no one [around the U.S.] had found it yet,” he said.

When it came back positive on the woman’s sample, he said he told his staff back to “absolutely, immediately” do further testing and do the entire genomic sequence to ensure the finding was accurate. That took five days of around-the-clock work to complete.

On May 23, with the finding confirmed by genetic sequencing, he put together a letter and sent it to the CDC. The CDC acknowledged that the next day and told the Pennsylvania Department of Health..

“It’s just a stroke of luck we now know it’s here,” Dr. McGann said.

Sean D. Hamill: shamill@post-gazette.com or 412-263-2579 or Twitter: @SeanDHamill